54182-58-0

Hexadeca-μ-hydroxytetracosahydroxy[μ8-[1,3,4,6-tetra-O-sulfo-β-Dfructofuranosyl-α-D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminu

C₁₂H₅₄Al₁₆O₇₅S₈

158.04

Sucralfate is a cytoprotective agent, an oral gastrointestinal medicationprimarily indicated for the treatment of active duodenal ulcers.Sucralfate is also used for the treatment of gastroesophageal reflux disease and stressulcers. Unlike the other classes of medications used for treatment of peptic ulcers, sucralfate is a sucrose sulfate-aluminium complex that binds to the mucosa, thus creating a physical barrier that impairs diffusion of hydrochloric acid in the gastrointestinal tract and prevents degradation of mucus by acid. It also stimulates bicarbonate output and acts like an acid buffer with cytoprotective properties. Sucralfate was approved by the U.S. Food and Drug Administration (FDA) in 1981.

50kgs drum

* FDA approved

* Micronized powder(50mm) could be supplied

Ms.Li Hui

E-mail:lihui@negpf.com.cn